+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Apheresis Equipment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

  • PDF Icon


  • 117 Pages
  • October 2021
  • Region: Global
  • Acute Market Reports
  • ID: 5616039
Rising incidence of hematological disorders has led to growth in demand for platelets and plasma products for efficient treatment and improvement in survival rates. The apheresis equipment market is expected to be driven by growth in incidence of blood disorders and technological innovations in nature and efficiency of apheresis equipment. Researchers, healthcare practitioners and device manufacturers worldwide are hence introducing solutions that demand minimum human intervention and allow agility to apheresis process.

For the purpose of this study, the global apheresis equipment market studied for product type, application, technology, procedure type and geographical distribution. Based on product types, this market is categorized into apheresis device and disposable kits segments. Membrane filtration and centrifugation are the two technologies adopted for performing apheresis. Apheresis finds major adoption in renal, neurology, hematology and other such applications. Based on procedure types, the global apheresis market is segmented into major procedures, namely, plasmapheresis, LDL-apheresis, plateletpheresis, leukapheresis, photophereis, erythrocytapheresis and others. Market size and forecast for each such mentioned segment for the period 2018-2029 along with respective CAGR for the period 2021-2029 are provided in this study, while analyzing the major market developments, commercial events, product positioning and movements by market players.

Geographically, the global apheresis equipment market is studied for the following regional markets:

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • Rest of Asia Pacific
  • Middle East and Africa
  • Latin America
Market size and forecast for these regional and country level markets are presented in this study for the period 2018-2029. Market growth rates for the forecast period 2021-2029 are also included in this report, considering 2020 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global apheresis equipment market. Tools such as market positioning of key players, Porter’s five forces analysis and attractive investment proposition provide the readers with insights on the competitive scenario of the global apheresis equipment market. This report concludes with company profiles section that highlights major information about the key players engaged in development, manufacture and sales of apheresis equipment market.

Based on procedure types, the apheresis equipment market is segmented into:

1. Plasmapheresis

2. LDL-apheresis

3. Plateletpheresis

4. Leukapheresis

5. Photophereis

6. Erythrocytapheresis

7. Others

Plasmapheresis accounts for the largest share of the apheresis equipment market. This procedure is used to segregate plasma from other blood cells. Growing demand for plasma products is the most significant driver for the progress of plasmapheresis market. Plasmapheresis procedure for first developed by Grifols in 1951. Bleeding and clotting disorders, cardiovascular diseases, and burn injuries are chief application areas of plasmapheresis. Drugs based on plasma products are also administered to patients with compromised or weak immune system. Growing incidence of hematological disorders is perpetually growing, thus giving rise to demand for plasma products, thus acting as a primary growth driver. Extracorporeal photopheresis, or photopheresis is a form of leukapheresis with an additional stage of photo-treatment. Photopheresis is approved by the FDA for treatment of cutaneous T-cell lymphoma and is also used for treating solid organ transplant rejection, type 1 diabetes, scleroderma, lichen planus, atopic dermatitis and pemphigus vulgaris. On the ground of growing prevalence of these diseases, the demand for both open and closes photopheresis systems is on the rise, and this growth will be witnessed through the forecast period.

Based on the type of products, the global apheresis equipment market is segmented as follows:

  • Apheresis Devices
  • Apheresis Disposable Kits
Moreover, membrane filtration and centrifugation are the two technologies used for performing apheresis procedure.

Apheresis disposable kits is the largest segment in the total apheresis equipment market. High purchase rate of disposable kits due to high usage volume, coupled with ever growing demand for apheresis procedures drive the growth of this segment. Filters, tubes, and other such products constitute the assembly of disposable kits. In order to curb the risk of infection, single use products are in high demand, where single cycle procedures consume multiple disposable parts. Such intensive consumption of disposables is responsible for larger revenue and volume share of disposable kits segment. The currently available apheresis devices constitute collection system, separator unit and data management system and others. The modern apheresis machines allow quick turnaround and safety from infections. The demand for apheresis devices is burgeoning in emerging markets of Asia Pacific and Latin America due to rapid development of healthcare infrastructure and growing demand for apheresis procedure.

Apheresis procedures find major application in hematology, renal, neurology and other treatment areas.

Neurology is the largest segment for apheresis equipment. Increasing prevalence of neurological diseases such as myasthenia gravis and multiple sclerosis is a chief factor contributing to the dominance of this segment. Perpetual widening application of apheresis and growth in R&D efforts aimed at introducing novel products in the market will further boost the market growth. Therapeutic plasma exchange is a crucial treatment for treating myasthenia gravis, Guillain-Barre syndrome, multiple sclerosis or chronic inflammatory demyelinating polyneuropathy. Increasing prevalence of such diseases and proven efficiency of apheresis in treating such conditions is a major driver of this application segment. The burden of sickle cell disease is phenomenally high. Red blood cell transfusion is used as an ideal treatment for sickle cell disease, which is a sub-type of therapeutic hemapheresis. Therapeutic plasma exchange, leukapheresis, photopheresis, plateletpheresis are also becoming popular for treating hematological diseases.

For the purpose of this study, the global apheresis equipment market is categorized as follows:

  • North America (U.S. & Canada)
  • Europe (Germany, U.K. & Rest of Europe)
  • Asia Pacific (Japan, China & Rest of Asia Pacific)
  • Latin America (LATAM)
  • Middle East and Africa (MEA)
North America holds over 45% of the global apheresis equipment market in 2020. Well-developed healthcare infrastructure, high awareness between both patients and care-givers and favorable reimbursement are the key drivers of this market. Centrifugation apheresis technology is anticipated to be in high demand in North America market during the forecast period. Increasing incidence of hematological and neurological disorders in Europe that demand apheresis procedure for treatment will drive the European apheresis equipment market. Additionally, Asia Pacific is anticipated to be the fastest progressing market for apheresis equipment during the forecast period. Increasing prevalence of blood disorders that demand treatment with platelets and plasma products in emerging markets of China, Japan, Australia, Korea and India is a key market driver of Asia Pacific market. Rapid development of healthcare infrastructure, and improving awareness in the general population will additionally contribute to demand for apheresis and hence apheresis equipment in the region.

This product will be delivered within 2 business days.

Table of Contents

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Market Portraiture: Apheresis Equipment Market
2.2 Global Apheresis Equipment Market, by Products and Technology, 2020 (USD Mn)
2.3 Global Apheresis Equipment Market Share, by Procedure Type, 2020 (Value %)
2.4 Global Apheresis Equipment Market, by Applications, 2020 (USD Mn)
2.5 Global Apheresis Equipment Market Share, by Geography, 2020 (Value %)
Chapter 3 Global Apheresis Equipment Market Overview
3.1 Overview
3.2 Market Dynamics
3.2.1 Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Market Inclination Insights
3.4 Major Commercial Events
3.5 Porter's Five Forces Model
3.6 Attractive Investment Proposition
3.7 Market Competition Assessment: Apheresis Equipment Market, by Key Players
Chapter 4 Global Apheresis Equipment Market, By Products, 2019-2029 (USD Mn)
4.1 Introduction
4.2 Apheresis Devices
4.3 Disposable Kits
Chapter 5 Global Apheresis Equipment Market, By Technology, 2019-2029 (USD Mn)
5.1 Introduction
5.2 Membrane Filtration
5.3 Centrifugation
Chapter 6 Global Apheresis Equipment Market, By Procedure Type, 2019-2029 (USD Mn)
6.1 Introduction
6.2 Plasmapheresis
6.3 LDL-apheresis
6.4 Plateletpheresis
6.5 Leukapheresis
6.6 Photophereis
6.7 Erythrocytapheresis
6.8 Others
Chapter 7 Global Apheresis Equipment Market, By Applications, 2019-2029 (USD Mn)
7.1 Introduction
7.2 Renal
7.3 Neurology
7.4 Hematology
7.5 Others
Chapter 8 Global Apheresis Equipment Market, By Geography, 2019-2029 (USD Mn)
8.1 Preface
8.2 North America (U.S. & Canada)
8.3 Europe (U.K., Germany & Rest of Europe)
8.4 Asia Pacific (Japan, China & Rest of Asia Pacific)
8.5 Latin America
8.6 Middle East and Africa
Chapter 9 Company Profiles
9.1 Haemonetics Corporation
9.2 Terumo BCT, Inc.
9.3 HemaCare Corporation
9.4 Asahi Kasei Kuraray Medical Co., Ltd.
9.5 Fenwal, Inc.
9.6 B Braun Melsungen AG
9.7 Medica SpA
9.8 Feresenius Kabi
9.9 Cerus Corporation
9.10 Kawasumi Laboratories Inc.
9.11 Kaneka Corporation
9.12 Nikkiso Co., Ltd.
9.13 Therakos, Inc.

Companies Mentioned

  • Haemonetics Corporation
  • Terumo BCT Inc.
  • HemaCare Corporation
  • Asahi Kasei Kuraray Medical Co. Ltd.
  • Fenwal Inc.
  • B Braun Melsungen AG
  • Medica SpA
  • Feresenius Kabi
  • Cerus Corporation
  • Kawasumi Laboratories Inc.
  • Kaneka Corporation